Literature DB >> 25016648

Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy.

Shuai Li, Wei Wu, Kemao Xiu, Fujian Xu, Zhongming Li, Jianshu Li.   

Abstract

Amphiphilic copolymers have been paid much attention for controlled drug release for many years due to their obvious advantages. In this study, an acid-triggered drug carrier system capable of rapid intracellular drug release is investigated for potential tumor therapy. The amphiphilic diblock copolymer poly(2-diisopropylaminoethyl methacrylate)-b-poly(2-aminoethyl methacrylate hydrochloride) (PDPA-b-PAMA) is prepared by atom transfer radical polymerization (ATRP). The molecular structure of the copolymer is confirmed by 1H NMR and gel permeation chromatography (GPC). The critical micelle concentration (CMC) value of the PDPA-b-PAMA is 0.005 mg/mL, which can ensure the thermodynamical stability of micelles even after significant dilution. The drug loading and encapsulation efficiencies of doxorubicin (DOX)-loaded micelles are 9.96% and 55.31%, respectively. Dynamic light scattering (DLS) and transmission electron microscope (TEM) show that the amphiphilic block copolymers self-assemble into spherical micelles with narrow polydispersity indexes (PDLs) at pH 7.4 and 6.8, but disassemble into random chain aggregations at pH 5.0. The DOX-loaded PDPA-b-PAMA shows obvious pH-responsive drug release profile when the pH value changes from 7.4 to 5.0, since it transforms from amphiphilicity to double hydrophilicity through the protonation of PDPA block (pK(a) - 6.2) in a relatively low pH condition, thus the loaded DOX can be rapidly released from the disassembling micelles. In addition, the micellar system also exhibits relatively low cytotoxicity and rapid drug release behaviour in tumor cells, which make it promising for tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25016648     DOI: 10.1166/jbn.2014.1846

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  7 in total

Review 1.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.

Authors:  Min Li; Peng Zou; Katherine Tyner; Sau Lee
Journal:  AAPS J       Date:  2016-11-10       Impact factor: 4.009

2.  Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.

Authors:  Dinesh Vyas; Nicolas Lopez-Hisijos; Sulakshana Gandhi; M El-Dakdouki; Marc D Basson; Mary F Walsh; X Huang; Arpita K Vyas; Lakshmi S Chaturvedi
Journal:  J Nanosci Nanotechnol       Date:  2015-09

3.  Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin.

Authors:  Chi Thanh Nguyen; Thanh Huyen Tran; Mansoor Amiji; Xiuling Lu; Rajeswari M Kasi
Journal:  Nanomedicine       Date:  2015-07-11       Impact factor: 5.307

Review 4.  Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.

Authors:  Binlong Chen; Wenbing Dai; Bing He; Hua Zhang; Xueqing Wang; Yiguang Wang; Qiang Zhang
Journal:  Theranostics       Date:  2017-01-07       Impact factor: 11.556

5.  Synthesis of crosslinkable diblock terpolymers PDPA-b-P(NMS-co-OEG) and preparation of shell-crosslinked pH/redox-dual responsive micelles as smart nanomaterials.

Authors:  Jingjing Sun; Zhao Wang; Amin Cao; Ruilong Sheng
Journal:  RSC Adv       Date:  2019-10-29       Impact factor: 4.036

6.  Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.

Authors:  Yan-feng Song; Dao-zhou Liu; Ying Cheng; Miao Liu; Wei-liang Ye; Bang-le Zhang; Xin-you Liu; Si-yuan Zhou
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

Review 7.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.